Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518088 · ClinicalTrials.gov registry record · NA
Effects of a Dietary Fiber on Fecal Microbiota and Metabolism
A NA study, sponsored by Ingredion Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01518088: Completed NA study, sponsored by Ingredion Incorporated.
NCT01518088 is a NA study that has completed, run by Ingredion Incorporated. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01518088, a NA study, has completed, sponsored by Ingredion Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to examine how a dietary fiber affects metabolism in healthy overweight and obese adults. The fiber will be added to foods that participants will consume for two, three-week periods. The fiber will be given in two doses -- 15 g per day during one period, and 30 g per day in the other. In another three-week period, they will consume the same foods, but with no fiber added. Major outcomes will include fermentability of the fiber, as assessed by measurement of breath hydrogen, as well as shifts in fecal bacteria. The caloric value of the fiber will be determined and metabolic measures related to blood glucose control and inflammation will also be taken.
Primary Outcome
Urine and feces will be collected for 7 days at the end of each treatment period to allow for assessment of metabolizable energy
Interventions
- DIETARY_SUPPLEMENT Dietary Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01518088 record still lists
NCT01518088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Dietary Fiber is the first listed.
NCT01518088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01518088 about?
NCT01518088 is a clinical study titled "Effects of a Dietary Fiber on Fecal Microbiota and Metabolism". The purpose of the study is to examine how a dietary fiber affects metabolism in healthy overweight and obese adults. The fiber will be added to foods that participants will consume for two, three-week periods. The fiber will be given in two doses -- 15 g per day during one period, and 30 g per day ...
What is the current status of trial NCT01518088?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01518088?
The interventions under investigation include: Dietary Fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01518088?
This trial is sponsored by Ingredion Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01518088's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia